Top Chinese Growth Stocks With High Insider Ownership For August 2024

As China's economic landscape continues to navigate through mixed signals and policy adjustments, the focus on growth companies with high insider ownership becomes increasingly relevant. In this environment, stocks with strong internal commitment often signal confidence from those who understand the business best, making them particularly noteworthy for investors seeking stability and potential in a fluctuating market.

Top 10 Growth Companies With High Insider Ownership In China

Name	Insider Ownership	Earnings Growth
Ningbo Sunrise Elc TechnologyLtd (SZSE:002937)	24.3%	27.7%
ShenZhen Woer Heat-Shrinkable MaterialLtd (SZSE:002130)	19%	27.9%
Anhui Huaheng Biotechnology (SHSE:688639)	31.5%	26.5%
Cubic Sensor and InstrumentLtd (SHSE:688665)	10.1%	34.3%
KEBODA TECHNOLOGY (SHSE:603786)	12.8%	25.1%
Arctech Solar Holding (SHSE:688408)	38.7%	28.4%
Suzhou Sunmun Technology (SZSE:300522)	36.5%	63.4%
Eoptolink Technology (SZSE:300502)	26.7%	39.4%
Sineng ElectricLtd (SZSE:300827)	36.5%	39.8%
UTour Group (SZSE:002707)	23%	36.1%

Click here to see the full list of 358 stocks from our Fast Growing Chinese Companies With High Insider Ownership screener.

Below we spotlight a couple of our favorites from our exclusive screener.

Jiangsu Sinopep-Allsino Biopharmaceutical (SHSE:688076)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. (SHSE:688076) is a biomedical company in China specializing in the R&D, production, sale, and technical service of peptides and small molecule drugs with a market cap of CN¥15.32 billion.

Operations: The company's revenue from medicine manufacturing is CN¥1.18 billion.

Insider Ownership: 15.8%

Earnings Growth Forecast: 36.4% p.a.

Jiangsu Sinopep-Allsino Biopharmaceutical is a growth company with high insider ownership in China. Its revenue is forecast to grow 31.8% per year, significantly outpacing the CN market's 13.6%. Earnings are expected to grow at 36.4% annually, also above the market average of 22.2%. The stock trades at a discount of 23.2% below its estimated fair value but has shown high volatility recently and has not seen substantial insider trading activity in the past three months.

• Click to explore a detailed breakdown of our findings in Jiangsu Sinopep-Allsino Biopharmaceutical's earnings growth report.
• Our valuation report unveils the possibility Jiangsu Sinopep-Allsino Biopharmaceutical's shares may be trading at a premium.

Bozhon Precision Industry TechnologyLtd (SHSE:688097)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Bozhon Precision Industry Technology Co., Ltd. develops, designs, produces, and sells automation equipment and related products both in China and internationally, with a market cap of CN¥9.40 billion.

Operations: Bozhon Precision Industry Technology Co., Ltd. generates CN¥4.70 billion in revenue from its Industrial Automation & Controls segment.

Insider Ownership: 29.3%

Earnings Growth Forecast: 30.7% p.a.

Bozhon Precision Industry Technology Ltd. is expected to see annual earnings growth of 30.7%, outpacing the CN market's 22.2%. Revenue is forecast to grow at 21.1% per year, also above the market average of 13.6%. Despite this promising growth outlook, the company's return on equity is projected to be low at 12.9% in three years, and its share price has been highly volatile recently without substantial insider trading activity in the past three months.

• Delve into the full analysis future growth report here for a deeper understanding of Bozhon Precision Industry TechnologyLtd.
• Our comprehensive valuation report raises the possibility that Bozhon Precision Industry TechnologyLtd is priced higher than what may be justified by its financials.

Naruida Technology (SHSE:688522)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Naruida Technology Co., Ltd. manufactures and sells polarized multifunctional active phased array radars in China, with a market cap of approximately CN¥10.79 billion.

Operations: The company generates revenue primarily from the production and sales of radar products, amounting to CN¥208.86 million.

Insider Ownership: 17.8%

Earnings Growth Forecast: 58.5% p.a.

Naruida Technology is forecast to see robust revenue growth of 52.3% per year, significantly outpacing the CN market's 13.6%. Earnings are expected to grow at 58.5% annually, also above the market average of 22.2%. However, its return on equity is projected to be low at 15.3% in three years, and profit margins have declined from 49.2% last year to 28.3%. There has been no substantial insider trading activity or share repurchases recently.

• Get an in-depth perspective on Naruida Technology's performance by reading our analyst estimates report here.
• Our expertly prepared valuation report Naruida Technology implies its share price may be too high.

Next Steps

• Take a closer look at our Fast Growing Chinese Companies With High Insider Ownership list of 358 companies by clicking here.
• Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks.
• Enhance your investing ability with the Simply Wall St app and enjoy free access to essential market intelligence spanning every continent.

Want To Explore Some Alternatives?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com